Deciphera Pharmaceuticals, Inc.
NASDAQ:DCPH
Overview | Financials
Company Name | Deciphera Pharmaceuticals, Inc. |
Symbol | DCPH |
Currency | USD |
Price | 25.59 |
Market Cap | 2,212,920,840 |
Dividend Yield | 0% |
52-week-range | 9.9 - 25.61 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Steven L. Hoerter |
Website | https://www.deciphera.com |
An error occurred while fetching data.
About Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD